Eric R. Pettipher

Person

Abingdon, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,980,927
- Issue date Mar 17, 2015
- Atopix Therapeutics Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,563,536
- Issue date Oct 22, 2013
- Atopix Therapeutics Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,536,158
- Issue date Sep 17, 2013
- Atopix Therapeutics Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,314,257
- Issue date Nov 20, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,198,314
- Issue date Jun 12, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,163,936
- Issue date Apr 24, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of CRTH2-mediated diseases and conditions
- Patent number 8,163,931
- Issue date Apr 24, 2012
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 7,919,512
- Issue date Apr 5, 2011
- Oxagen Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 7,750,027
- Issue date Jul 6, 2010
- Oxagen Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the treatment of CRTH2-mediated diseases and conditions
- Patent number 7,582,672
- Issue date Sep 1, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20150246030
- Publication date Sep 3, 2015
- Atopix Therapeutics Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20140039012
- Publication date Feb 6, 2014
- Atopix Therapeutics Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Condit...
- Publication number 20130052190
- Publication date Feb 28, 2013
- Oxagen Limited
- Lisa Pearce Collins
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20110142855
- Publication date Jun 16, 2011
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20110123547
- Publication date May 26, 2011
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of CRTH2 Antagonist Compounds
- Publication number 20110124683
- Publication date May 26, 2011
- Oxagen Limited
- Michael George Hunter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20100266535
- Publication date Oct 21, 2010
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20100063103
- Publication date Mar 11, 2010
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20090186923
- Publication date Jul 23, 2009
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090023788
- Publication date Jan 22, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090018138
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-mediated diseases and conditions
- Publication number 20090018139
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of CRTH2-Mediated diseases and conditions
- Publication number 20090018338
- Publication date Jan 15, 2009
- Oxagen Limited
- David Middlemiss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having Crth2 Antagonist Activity
- Publication number 20070232681
- Publication date Oct 4, 2007
- Oxagen Limited
- David Middlemiss
- C07 - ORGANIC CHEMISTRY

Eric R. Pettipher

Person

Patents Grantslast 30 patents

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

Compounds for the treatment of CRTH2-mediated diseases and conditions

Patents Applicationslast 30 patents

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Condit...

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

Use of CRTH2 Antagonist Compounds

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-mediated diseases and conditions

Treatment of CRTH2-Mediated diseases and conditions

Compounds Having Crth2 Antagonist Activity